Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
about
Prognostic significance of hepatocyte growth factor activator inhibitor type 1 (HAI-1) immunoreactivity in pancreatic ductal adenocarcinoma.Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer.Neoadjuvant therapy offers longer survival than upfront surgery for poorly differentiated and higher stage pancreatic cancer.Lymph node 8a as a prognostic marker for poorer prognosis in pancreatic and periampullary carcinoma.
P2860
Re-evaluation of classical prognostic factors in resectable ductal adenocarcinoma of the pancreas
description
2016 nî lūn-bûn
@nan
2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@ast
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@en
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@nl
type
label
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@ast
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@en
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@nl
prefLabel
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@ast
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@en
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@nl
P2093
P2860
P356
P1476
Re-evaluation of classical pro ...... adenocarcinoma of the pancreas
@en
P2093
Daniel Ansari
Daniel Åkerberg
Roland Andersson
P2860
P304
P356
10.3748/WJG.V22.I28.6424
P407
P577
2016-07-28T00:00:00Z